Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients?

被引：11
|
作者：
Emmel, V. E. [2 ]
Alonso, I. [3 ]
Jardim, L. B. [4 ]
Saraiva-Pereira, M. L. [1 ,2 ,5 ]
Sequeiros, J. [3 ]
机构：
[1] Hosp Clin Porto Alegre, Lab Identificacao Genet, Ctr Pesquisa Expt, Serv Genet Med, BR-90035903 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Dept Genet, BR-90046900 Porto Alegre, RS, Brazil
[3] Univ Porto, UnIGENe, IBMC, Inst Mol & Cell Biol, Oporto, Portugal
[4] Univ Fed Rio Grande do Sul, Dept Med Interna, BR-90046900 Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul, Dept Bioquim, BR-90046900 Porto Alegre, RS, Brazil
来源：
CLINICAL GENETICS | 2011年 / 79卷 / 01期
关键词：
MACHADO-JOSEPH DISEASE;
D O I：
10.1111/j.1399-0004.2010.01508.x
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：100 / 102
页数：3
相关论文
共 50 条
  • [1] Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD
    Wang, Chunrong
    Peng, Huirong
    Li, Jiada
    Ding, Dongxue
    Chen, Zhao
    Long, Zhe
    Peng, Yun
    Zhou, Xin
    Ye, Wei
    Li, Kai
    Xu, Qian
    Ai, Sanxi
    Song, Chengyuan
    Weng, Ling
    Qiu, Rong
    Xia, Kun
    Tang, Beisha
    Jiang, Hong
    NEUROBIOLOGY OF AGING, 2017, 53 : 192.e5 - 192.e10
  • [2] Two Novel SNPs in ATXN3 3′ UTR May Decrease Age at Onset of SCA3/MJD in Chinese Patients
    Long, Zhe
    Chen, Zhao
    Wang, Chunrong
    Huang, Fengzhen
    Peng, Huirong
    Hou, Xuan
    Ding, Dongxue
    Ye, Wei
    Wang, Junling
    Pan, Qian
    Li, Jiada
    Xia, Kun
    Tang, Beisha
    Ashizawa, Tetsuo
    Jiang, Hong
    PLOS ONE, 2015, 10 (02):
  • [3] Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
    Moore, Lauren R.
    Rajpal, Gautam
    Dillingham, Ian T.
    Qutob, Maya
    Blumenstein, Kate G.
    Gattis, Danielle
    Hung, Gene
    Kordasiewicz, Holly B.
    Paulson, Henry L.
    McLoughlin, Hayley S.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 200 - 210
  • [4] ATXN3L: may an assumed pseudogene compensate partial loss-of-function of normal ATXN3 in Machado-Joseph disease (MJD/SCA3)?
    Costa, I. P. D.
    Lopes, A. M.
    Seixas, S.
    Sequeiros, J.
    Amorim, A.
    Martins, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 370 - 370
  • [5] Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice
    Rodriguez-Lebron, Edgardo
    Costa, Maria doCarmo
    Luna-Cancalon, Katiuska
    Peron, Therese M.
    Fischer, Svetlana
    Boudreau, Ryan L.
    Davidson, Beverly L.
    Paulson, Henry L.
    MOLECULAR THERAPY, 2013, 21 (10) : 1909 - 1918
  • [6] CAG repeat extension correlates with age of onset but does not explain anticipation in Dutch SCA3/MJD family
    Brunt, ERP
    Verschuuren, CC
    Mensink, RGJ
    Joosten, A
    Stolte, I
    Scheffer, H
    NEUROLOGY, 1996, 46 (02) : 2100 - 2100
  • [7] Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3
    Gao, Rui
    Liu, Yongping
    Silva-Fernandes, Anabela
    Fang, Xiang
    Paulucci-Holthauzen, Adriana
    Chatterjee, Arpita
    Zhang, Hang L.
    Matsuura, Tohru
    Choudhary, Sanjeev
    Ashizawa, Tetsuo
    Koeppen, Arnulf H.
    Maciel, Patricia
    Hazra, Tapas K.
    Sarkar, Partha S.
    PLOS GENETICS, 2015, 11 (01):
  • [8] MicroRNA profiling in the serums of SCA3/MJD patients
    Shi, Yuting
    Huang, Fengzhen
    Tang, Beisha
    Li, Jiada
    Wang, Junling
    Shen, Lu
    Xia, Kun
    Jiang, Hong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (02) : 97 - 101
  • [9] Polyglutamine-expanded ataxin3 alter specific gene expressions through changing DNA methylation status in SCA3/MJD
    Ding, Dongxue
    Wang, Chunrong
    Chen, Zhao
    Xia, Kun
    Tang, Beisha
    Qiu, Rong
    Jiang, Hong
    AGING-US, 2021, 13 (03): : 3680 - 3698
  • [10] Safety and efficacy of valproic acid treatment in SCA3/MJD patients
    Lei, Li-Fang
    Yang, Guo-Ping
    Wang, Jun-Ling
    Chuang, De-Maw
    Song, Wei-Hong
    Tang, Bei-Sha
    Jiang, Hong
    PARKINSONISM & RELATED DISORDERS, 2016, 26 : 55 - 61
12345